Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03407287 · ClinicalTrials.gov registry record
Peripheral Venous Analysis (PIVA) for Predicting Volume Responsiveness and Fluid Status
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Terminated
- Registry status
- 180
- Enrollment target
NCT03407287 is a clinical trial that was terminated before completion, run by Vanderbilt University Medical Center. The registered enrollment target is 180 participants.
The verdict
NCT03407287 was terminated before completion, sponsored by Vanderbilt University Medical Center.
- TERMINATED
- Registry status
- 180 participants
- Enrollment target
Study Summary
The aim of this study is to determine the effects of fluid alternations, hemodynamic changes, mechanical ventilation, pharmacologic agents, positional changes, and comorbidities on the Peripheral Intravenous waveform Analysis (PIVA) signal.
Interventions
- PROCEDURE Peripheral Intravenous Analysis (PIVA)
- PROCEDURE Standard of care invasive vascular monitoring
- PROCEDURE Standard noninvasive vascular monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2018-01-08 |
| Est. Completion | 2020-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03407287
The ClinicalTrials.gov registry entry for NCT03407287 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Peripheral Intravenous Analysis (PIVA) is the first listed.
NCT03407287 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03407287 about?
NCT03407287 is a clinical study titled "Peripheral Venous Analysis (PIVA) for Predicting Volume Responsiveness and Fluid Status". The aim of this study is to determine the effects of fluid alternations, hemodynamic changes, mechanical ventilation, pharmacologic agents, positional changes, and comorbidities on the Peripheral Intravenous waveform Analysis (PIVA) signal.
What is the current status of trial NCT03407287?
This trial is currently terminated. The enrollment target is 180 participants. The study started on 2018-01-08. Estimated completion is 2020-12-01.
What interventions are being tested in trial NCT03407287?
The interventions under investigation include: Peripheral Intravenous Analysis (PIVA) (PROCEDURE), Standard of care invasive vascular monitoring (PROCEDURE), Standard noninvasive vascular monitoring (PROCEDURE).
Who is sponsoring clinical trial NCT03407287?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.